Ondansetron HCL 4 mg Film-Coated Oral Tablet, 30 Tablets/Bottle

Ondansetron Hydrochloride — 4MG, Film-coated tablet, bottle of 30 tablets

Ondansetron Hydrochloride is a film-coated tablet for oral use. Ondansetron tablets are indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 initial and repeat courses of moderately emetogenic cancer chemotherapy radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen Ondansetron tablets are also indicated for the prevention of postoperative nausea and/or vomiting. Ondansetron tablets are a 5-HT 3 receptor antagonist indicated for the prevention of: nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 . (1) nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. (1) nausea and vomiting associated with radiotherapy in patients rece

• Active ingredient or product type: ONDANSETRON HYDROCHLORIDE
• Strength/concentration: 4MG
• Dosage form and route: Film-coated tablet, Oral
• Exact package presentation: bottle of 30 tablets
• NDC/item number: 57237-075-30
• Manufacturer: RISING PHARM
• Storage/handling: Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Protect from light.
• Status: Rx only

Important safety information: Hypersensitivity Reactions, Including Anaphylaxis and Bronchospasm : Discontinue ondansetron if suspected.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.